Attached files

file filename
8-K - 8-K - Pacira BioSciences, Inc.pcrx8-kdec2015.htm


Exhibit 16.1

 


December 14, 2015
 
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-7561
 
Dear Sirs/Madams:
 
We have read the statements made by Pacira Pharmaceuticals, Inc., which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K, as part of the Form 8-K of Pacira Pharmaceuticals, Inc. dated December 17, 2015. We agree with the statements concerning our Firm in such Form 8-K.

Very truly yours,

Roseland, New Jersey